Consistent with its anti-NF-κB activity, DMF inhibited mammosphere formation (a functional measure of cancer stem cell properties), cell proliferation and xenograft tumour growth [110], providing proof-of-concept evidence for the clinical potential of DMF in breast cancer therapy. This evidence concerns the gene NFKB1 and breast cancer.